S
Santanu Raychaudhuri
Researcher at University of California, Los Angeles
Publications - 16
Citations - 949
Santanu Raychaudhuri is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Viral replication & Internal ribosome entry site. The author has an hindex of 13, co-authored 16 publications receiving 846 citations.
Papers
More filters
Journal ArticleDOI
Histone Code Modifications Repress Glucose Transporter 4 Expression in the Intrauterine Growth-restricted Offspring
TL;DR: It is concluded that epigenetic mechanisms consisting of histone code modifications repress skeletal muscle glut4 transcription in the postnatal period and persist in the adult female IUGR offspring.
Journal ArticleDOI
The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.
Oscar Gonzalez,Vanessa Fontanes,Santanu Raychaudhuri,Rachel R. Ogorzalek Loo,Joseph A. Loo,Vaithilingaraja Arumugaswami,Ren Sun,Asim Dasgupta,Samuel W. French +8 more
TL;DR: The marked inhibition of virus production by Quercetin may partially be related to reduction of HSP40 and HSP70 and their potential involvement in IRES translation, as well as viral morphogenesis or secretion.
Journal ArticleDOI
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.
Amit Ganguly,Robert A. McKnight,Santanu Raychaudhuri,Bo-Chul Shin,Zhigui Ma,Kelle H. Moley,Sherin U. Devaskar +6 more
TL;DR: It is concluded that GLUT3 mutations cause a gene dose-dependent early pregnancy loss or late-gestation fetal growth restriction despite the presence of embryonic and placental GLUT1 and a compensatory increase in system A amino acid placental transport.
Journal ArticleDOI
Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off.
TL;DR: It is demonstrated that both 3CD and 3D are capable of entering the nucleus in PV-infected cells, however, both polypeptides remain in the cytoplasm in uninfected HeLa cells, suggesting that both the 3D NLS and PV infection are required for the entry of 3CD into the nucleus.
Journal ArticleDOI
Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle.
Ronik Khachatoorian,Vaithilingaraja Arumugaswami,Vaithilingaraja Arumugaswami,Santanu Raychaudhuri,George K. Yeh,Eden M. Maloney,Julie Wang,Asim Dasgupta,Samuel W. French +8 more
TL;DR: It is demonstrated that catechin, naringenin, and quercetin possess significant antiviral activity, with no associated cytotoxicity, and combination of these bioflavonoids may act synergistically against HCV.